|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
O'Shaughnessy, Joyce; Schwartzberg, Lee; Piccart, Martine; Rugo, Hope S.; Yardley, Denise A.; Cortes, Javier; Untch, Michael; Harbeck, Nadia; Wright, Gail S.; Bondarenko, Igor; Glaspy, John; Nowecki, Zbigniew; Kayali, Fadi; Chan, Arlene; Levy, Christelle; Liu, Mei-Ching; Kim, Sung-Bae; Lemieux, Julie; Manikhas, Alexey; Tolaney, Sara; Lim, Elaine; Gombos, Andrea; Stradella, Agostina; Pegram, Mark; Fasching, Peter; Mangel, Laszlo; Semiglazov, Vladimir; Dieras, Veronique; Gianni, Luca; Danso, Michael A.; Vacirca, Jeff; Kroll, Stew; O'Connell, Joseph; Tang, Kevin; Wei, Thomas und Seidman, Andrew
(2021):
Results From CONTESSA: A Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2-, Hormone Receptor+ Metastatic Breast Cancer Who Have Previously Received a Taxane.
In: Clinical Advances in Hematology & Oncology, Bd. 19, Nr. 2: S. 12-13
Liu, Minetta C.; Janni, Wolfgang; Georgoulias, Vassilis; Yardley, Denise A.; Harbeck, Nadia; Wei, Xin; McGovern, Desmond und Beck, Robert
(2019):
First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial.
In: Cancer Management and Research, Bd. 11: S. 10427-10433
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2016):
Erratum to: Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (vol 16, pg 575, 2015).
In: Trials
17
[PDF, 357kB]
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glueck, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2015):
Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
In: Trials
16:575
[PDF, 1MB]